Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 71 for CHRONIC LYMPHOCYTIC LEUKEMIA

Edit search filters
  1. A Study To Evaluate The Safety And Tolerability Of KTE-X19 In Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia And Small Lymphocytic Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

    Scottsdale/Phoenix, AZ

  3. A Study To Evaluate The Efficacy And Safety Of Lenalidomide As Maintenance Therapy For Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

    Jacksonville, FL

  4. Elevate CLL R/R: Study Of Acalabrutinib (ACP-196) Versus Ibrutinib In Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Phase 1/2 Study Of CYT-0851 In B-Cell Malignancies And Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study Of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) In Participants With Chronic Lymphocytic Leukemia (CLL) And Other B-cell Malignancies

    Rochester, MN

  7. A Study To Determine Dose, Safety, And Efficacy Of Durvalumab As Monotherapy And In Combination Therapy In Subjects With Lymphoma Or Chronic Lymphocytic Leukemia

    Rochester, MN

  8. Epidemiology Of Chronic Lymphocytic Leukemia

    Rochester, MN

  9. informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

    Jacksonville, FL

  10. A Study Of Hematopoiesis In Patients With Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), And Healthy Controls

    Rochester, MN

.

Mayo Clinic Footer